Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,320 papers from all fields of science
Search
Sign In
Create Free Account
glyfoline
Known as:
1,6-dihydroxy-10-methyl-2,3,4,5-tetramethoxyacridin-9-one
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Acridines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Glyfoline induces mitotic arrest and apoptosis via alteration of mitotic spindles in cancer cell lines
Yi-Chen Wu
,
Wen-Yen Yen
,
T. Su
,
L. Yih
2007
Corpus ID: 87918365
A39 Glyfoline is an antineoplastic 9-acridone alkaloid isolated from Glycosmis citrifolia. Previous studies revealed that this…
Expand
2005
2005
Cytochrome C release induces apoptosis of nasopharyngeal carcinoma (NPC) by antitumor glyfoline.
T. Su
,
Hwei-Ming Huang
,
Chung‐kwe Wang
,
Han‐Chung Wu
,
Chin-Tarng Lin
Planta Medica
2005
Corpus ID: 36320643
The mechanism of action, leakage of cytochrome c from mitochondria into cytosol, for the antineoplastic compound glyfoline was…
Expand
2000
2000
Synthesis of biotinylated glyfoline for immunoelectron microscopic localization.
T. Su
,
C. Lin
,
C. H. Chen
,
H. M. Huang
Bioconjugate chemistry
2000
Corpus ID: 28698477
Antineoplastic glyfoline (1) has potent antitumor efficacy against various murine and human solid tumors. To elucidate the actual…
Expand
1992
1992
Synthesis of the acridone alkaloids glyfoline and congeners. Structure-activity relationship studies of cytotoxic acridones.
T.-L. Su
,
Bernd Kohler
,
Ting-Chao Chou
,
Moon Woo Chun
,
Kyoichi A. Watanabe
Journal of Medicinal Chemistry
1992
Corpus ID: 24965213
Glyfoline (4, 1,6-dihydroxy-10-methyl-2,3,4,5-tetramethoxyacridin-9-one) and its congeners were synthesized for evaluation of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE